Recruiting
Phase 1

PAS-004 in Patients With Advanced Solid Tumors

Sponsor:

Pasithea Therapeutics Corp.

Code:

NCT06299839

Conditions

RAS Mutation

NF1 Mutation

RAF Mutation

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PAS-004 Capsules

PAS-004 Tablets

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information